- Home
- IZEA vs PRLD Comparison
IZEA vs PRLD Comparison
Compare IZEA & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZEA
- PRLD
- Stock Information
- Founded
- IZEA 2006
- PRLD 2016
- Country
- IZEA United States
- PRLD United States
- Employees
- IZEA N/A
- PRLD N/A
- Industry
- IZEA Advertising
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- IZEA Consumer Discretionary
- PRLD Health Care
- Exchange
- IZEA Nasdaq
- PRLD Nasdaq
- Market Cap
- IZEA 69.1M
- PRLD 69.1M
- IPO Year
- IZEA N/A
- PRLD 2020
- Fundamental
- Price
- IZEA $5.05
- PRLD $1.57
- Analyst Decision
- IZEA
- PRLD Strong Buy
- Analyst Count
- IZEA 0
- PRLD 3
- Target Price
- IZEA N/A
- PRLD $4.00
- AVG Volume (30 Days)
- IZEA 184.4K
- PRLD 3.7M
- Earning Date
- IZEA 11-12-2025
- PRLD 11-12-2025
- Dividend Yield
- IZEA N/A
- PRLD N/A
- EPS Growth
- IZEA N/A
- PRLD N/A
- EPS
- IZEA N/A
- PRLD N/A
- Revenue
- IZEA $36,176,492.00
- PRLD $10,500,000.00
- Revenue This Year
- IZEA $11.15
- PRLD N/A
- Revenue Next Year
- IZEA $17.64
- PRLD N/A
- P/E Ratio
- IZEA N/A
- PRLD N/A
- Revenue Growth
- IZEA 7.12
- PRLD 250.00
- 52 Week Low
- IZEA $1.68
- PRLD $0.61
- 52 Week High
- IZEA $5.86
- PRLD $4.22
- Technical
- Relative Strength Index (RSI)
- IZEA 51.42
- PRLD 50.29
- Support Level
- IZEA $4.78
- PRLD $1.50
- Resistance Level
- IZEA $5.16
- PRLD $1.69
- Average True Range (ATR)
- IZEA 0.42
- PRLD 0.18
- MACD
- IZEA -0.04
- PRLD -0.02
- Stochastic Oscillator
- IZEA 61.45
- PRLD 70.38
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.